QX006N is a humanized monoclonal antibody inhibitor targeting human interferon alpha/beta receptor 1 (IFNAR1). QX006N is promising for research of systemic lupus erythematosus (SLE) and other IFNAR1-related autoimmune diseases[1].
Target:
IFNAR
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
